Company intelligence / Profile preview
Sihuan Pharmaceutical
- Ownership
- Private
- Employees
- ~2870
- Development stage
- Other
Overview
Sihuan Pharmaceutical has a broad commercial portfolio with over sixty marketed drugs and more than thirty products in late-stage development or clinical trials. The company is especially strong in diabetes/metabolic disease, with several innovative drugs such as new insulin analogs and oral antidiabetics advancing through Phase II/III trials or NDA submission. Its gastroenterology program includes Anaprazole sodium in Phase III for duodenal ulcer, which has shown efficacy in completed Phase II studies. The company also maintains a significant presence in medical aesthetics.
- Therapeutic areas
- GastroenterologyPulmonologyCardiovascularMetabolic DisordersOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculesBiosimilarsHormonesRecombinant polypeptidesSynthetic peptides
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Sihuan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sihuan Pharmaceutical.